2025 ISAKOS Congress in Munich, Germany

2025 ISAKOS Biennial Congress ePoster

 

Ten-Year Outcomes Of Hip Arthroscopy In Patients With Workers Compensation Claims

Roger Quesada Jimenez, MD, Des Plaines, Illinois UNITED STATES
Ady Haim Kahana Rojkind, MD, Des Plaines, IL UNITED STATES
Drashti Sikligar, MEng, Des Plaines, IL UNITED STATES
Jessica C. Keane, BS, Des Plaines, IL UNITED STATES
Tyler R. McCarroll, MD, Des Plaines, IL UNITED STATES
Benjamin G. Domb, MD, Des Plaines, Illinois UNITED STATES

American Hip Institute Research Foundation, Des Plaines, Illinois, UNITED STATES

FDA Status Cleared

Summary

Hip arthroscopy for the treatment of for femoroacetabular impingement and labral tear in patients with Worker's compensation claims showed favorable outcomes and a high return-to-work rate at a minimum 10-year follow-up

ePosters will be available shortly before Congress

Abstract

Purpose

To determine the impact Worker’s compensation (WC) status has on outcomes for patients undergoing hip arthroscopy for femoroacetabular impingement (FAI) and labral tears at a minimum 10-year follow-up, and to compare these findings with a propensity score–matched benchmark control group.

Methods

Retrospectively analyzed data for patients who underwent hip arthroscopy as treatment for FAI and labral tears between 2008 and 2013 with WC claims. Included patients completed pre- and postoperative questionnaires at minimum 10-year follow-up for patient reported outcomes (PROs) or documented an endpoint. Patients were propensity matched in a 1:3 ratio to a benchmark control group without WC claims based on age at surgery, sex, body mass index (BMI), acetabular outerbridge grade and capsular treatment. Clinically significant thresholds, complications, revision hip arthroscopy and survivorship rates, and type of work and return to work rates were analyzed.

Results

280 patients were included in the study. When compared to the benchmark control group, the WC group started with significantly lower baseline preoperative scores for PROs but had a significantly greater magnitude of improvement. The groups reached MCID and PASS for mHHS, NAHS, HOS-SSS, and VAS at similar rates at the latest follow-up. 82.9% of WC patients were able to return to work at an average of 8.04 ± 7.40 months. WC patients showed a higher revision hip arthroscopy rate (p < 0.05).

Conclusion

Hip arthroscopy for the treatment of FAI and labral tear in patients with WC claims showed favorable outcomes and a high return-to-work rate at a minimum 10-year follow-up. These results were comparable to a benchmark control group. However, the WC group had a significantly higher rate of revision hip arthroscopy with a 3-fold relative risk (95% CI [1.59 to 5.68], p < 0.001).